Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 149
Filter
1.
Br J Cancer ; 117(9): 1396-1404, 2017 Oct 24.
Article in English | MEDLINE | ID: mdl-28859056

ABSTRACT

BACKGROUND: Variation in colon cancer mortality occurring shortly after diagnosis is widely reported between socio-economic status (SES) groups: we investigated the role of different prognostic factors in explaining variation in 90-day mortality. METHODS: National cancer registry data were linked with national clinical audit data and Hospital Episode Statistics records for 69 769 adults diagnosed with colon cancer in England between January 2010 and March 2013. By gender, logistic regression was used to estimate the effects of SES, age and stage at diagnosis, comorbidity and surgical treatment on probability of death within 90 days from diagnosis. Multiple imputations accounted for missing stage. We predicted conditional probabilities by prognostic factor patterns and estimated the effect of SES (deprivation) from the difference between deprivation-specific average predicted probabilities. RESULTS: Ninety-day probability of death rose with increasing deprivation, even after accounting for the main prognostic factors. When setting the deprivation level to the least deprived group for all patients and keeping all other prognostic factors as observed, the differences between deprivation-specific averaged predicted probabilities of death were greatly reduced but persisted. Additional analysis suggested stage and treatment as potential contributors towards some of these inequalities. CONCLUSIONS: Further examination of delayed diagnosis, access to treatment and post-operative care by deprivation group may provide additional insights into understanding deprivation disparities in mortality.


Subject(s)
Colonic Neoplasms/epidemiology , Colonic Neoplasms/mortality , Social Class , Socioeconomic Factors , Adolescent , Adult , Aged , Aged, 80 and over , Cohort Studies , Colonic Neoplasms/pathology , England/epidemiology , Female , Follow-Up Studies , Humans , Male , Middle Aged , Neoplasm Staging , Prognosis , Risk Factors , Survival Rate , Young Adult
2.
Bone Marrow Transplant ; 49(9): 1155-61, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24978139

ABSTRACT

Hematopoietic cell transplantation (HCT) is used for treatment of hematopoietic diseases. Assessment of T- and B-cell reconstitution after HCT is crucial because poor immune recovery has a major effect on the clinical course. In this study, we retrospectively analyzed T-cell receptor excision circles (TRECs) as well as signal and coding joint kappa-deleting recombination excision circles (sjKRECs and cjKRECs, respectively) as markers of newly produced lymphocytes in 133 patients (56 primary immunodeficient and 77 malignant cases, median (range): 12 (0-62) years old). We analyzed the kinetics of TREC and KREC recovery and determined the factors that contributed to better immune recovery. KRECs became positive earlier than TRECs and increased thereafter. Younger recipient age had a favorable effect on recovery of sjKRECs and cjKRECs. Compared with BM and peripheral blood, our data suggested that cord blood (CB) provided rapid B-cell recovery. CB also provided better B-cell neogenesis in adult HCT recipients. Chronic GVHD was associated with low TRECs, but not increased sjKRECs/cjKRECs. Finally, positive sjKRECs 1 month after HCT were associated with fewer infectious episodes. Monitoring of TRECs and KRECs may serve as a useful tool for assessment of immune reconstitution post HCT.


Subject(s)
B-Lymphocytes/cytology , Fetal Blood/transplantation , Hematologic Diseases/therapy , Hematopoietic Stem Cell Transplantation/methods , Adolescent , Adult , B-Lymphocytes/immunology , Child , Child, Preschool , Female , Hematologic Diseases/immunology , Hematopoietic Stem Cell Transplantation/adverse effects , Humans , Infant , Infant, Newborn , Male , Middle Aged , Receptors, Antigen, T-Cell/blood , Receptors, Antigen, T-Cell/immunology , Retrospective Studies , Transplantation Conditioning/methods , Young Adult
4.
Transl Psychiatry ; 2: e119, 2012 May 22.
Article in English | MEDLINE | ID: mdl-22832963

ABSTRACT

Phenylalanine is an essential amino acid required for the synthesis of catecholamines including dopamine. Altered levels of phenylalanine and its metabolites in blood and cerebrospinal fluid have been reported in schizophrenia patients. This study attempted to examine for the first time whether phenylalanine kinetics is altered in schizophrenia using L-[1-(13)C]phenylalanine breath test ((13)C-PBT). The subjects were 20 chronically medicated schizophrenia patients (DSM-IV) and the same number of age- and sex-matched controls. (13)C-phenylalanine (99 atom% (13)C; 100 mg) was administered orally and the breath (13)CO(2) /(12)CO(2) ratio was monitored for 120 min. The possible effect of antipsychotic medication (risperidone (RPD) or haloperidol (HPD) treatment for 21 days) on (13)C-PBT was examined in rats. Body weight (BW), age and diagnostic status were significant predictors of the area under the curve of the time course of Δ(13)CO(2) (‰) and the cumulative recovery rate (CRR) at 120 min. A repeated measures analysis of covariance controlled for age and BW revealed that the patterns of CRR change over time differed between the patients and controls and that Δ(13)CO(2) was lower in the patients than in the controls at all sampling time points during the 120 min test, with an overall significant difference between the two groups. Chronic administration of RPD or HPD had no significant effect on (13)C-PBT indices in rats. Our results suggest that (13)C-PBT is a novel laboratory test that can detect altered phenylalanine kinetics in chronic schizophrenia patients. Animal experiments suggest that the observed changes are unlikely to be attributable to antipsychotic medication.


Subject(s)
Carbon Isotopes , Phenylalanine/pharmacokinetics , Schizophrenia/diagnosis , Adult , Animals , Antipsychotic Agents/therapeutic use , Breath Tests , Chronic Disease , Dopamine/physiology , Haloperidol/therapeutic use , Humans , Male , Middle Aged , Rats , Rats, Wistar , Risperidone/therapeutic use , Schizophrenia/drug therapy , Schizophrenia/physiopathology , Spectrophotometry, Infrared
5.
Kyobu Geka ; 63(1): 82-5, 2010 Jan.
Article in Japanese | MEDLINE | ID: mdl-20077837

ABSTRACT

A 38-year-old man was hospitalized complaining of an episode of syncope. He was diagnosed with acute infective endocarditis (IE) of the aortic and the mitral valves with mobile and large vegetations, complicated with mycotic cerebral emboli related to the left anterior and the middle cerebral arteries. Double valve replacement with mechanical prosthesis was performed within 24 hours after cerebral accident occurred. On the 36 postoperative day, emergency cerebrovascular surgery was done due to rupture of a mycotic intracranial aneurysm. He was discharged on foot without any neurological abnormal finding. The optimum treatment of IE complicated with cerebral embolism is a controversial theme. Management should be considered carefully in individual cases.


Subject(s)
Aneurysm, Ruptured/complications , Endocarditis, Bacterial/complications , Intracranial Aneurysm/complications , Adult , Aneurysm, Ruptured/surgery , Endocarditis, Bacterial/surgery , Humans , Intracranial Aneurysm/surgery , Male , Postoperative Complications
6.
Haemophilia ; 16(2): 290-5, 2010 Mar.
Article in English | MEDLINE | ID: mdl-19925628

ABSTRACT

SUMMARY: Between 2000 and 2008, 11 major orthopaedic surgeries for 7 congenital haemophilia patients with inhibitors were performed by the first author as the primary doctor using recombinant activated factor VII (rFVIIa). Orthopaedic surgical treatments were performed for six surgeries for four high-responder haemophilia A patients, three surgeries for two high-responder haemophilia B patients and two surgeries for one low-responder haemophilia B patient. This low-responder patient is allergic to factor IX products, so he usually uses rFVIIa as a haemostatic agent. All of the surgeries were major, such as joint arthroplasty, arthroscopic synovectomy, and a combination of both, and excellent surgical results were achieved. Seven cases were controlled by bolus infusion of rFVIIa, and the other four cases were controlled by combined bolus and continuous infusion of rFVIIa. An anti-fibrolytic agent was used for all cases. There were no thrombogenic adverse effects, only two bleeding episodes. As for haemostatic control, nine surgeries were excellent, one was good and one was fair. This report is the largest clinical report on major orthopaedic surgeries at a single institute. We have concluded that the combination of bolus and continuous infusion of rFVIIa is safe and effective, and more convenient to administer than simple bolus infusion therapy to achieve haemostasis at peri-operative periods. In addition, our data also concurs with the data of several previous reports which showed that orthopaedic surgery for haemophilia patients with inhibitors by means of rFVIIa is safe and effective.


Subject(s)
Blood Loss, Surgical/prevention & control , Factor VIIa/therapeutic use , Hemophilia A/drug therapy , Hemophilia A/surgery , Hemophilia B/drug therapy , Hemophilia B/surgery , Hemostatics/therapeutic use , Musculoskeletal Diseases/surgery , Adolescent , Adult , Blood Coagulation Factor Inhibitors/blood , Child , Hemophilia A/immunology , Hemophilia B/immunology , Hemostasis, Surgical , Humans , Middle Aged , Musculoskeletal Diseases/drug therapy , Musculoskeletal Diseases/immunology , Recombinant Proteins/therapeutic use
7.
Leukemia ; 24(2): 383-96, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20033052

ABSTRACT

We report the long-term results of Tokyo Children's Cancer Study Group's studies L84-11, L89-12, L92-13, and L95-14 for 1846 children with acute lymphoblastic leukemia, which were conducted between 1984 and 1999. The value of event-free survival (EFS)+/-s.e. was 67.2+/-2.2% at 10 years in L84-11, which was not improved in the following two studies, and eventually improved to 75.0+/-1.8% at 10 years in L95-14 study. The lower EFS of the L89-12 reflected a high rate of induction failure because of infection and delayed remission in very high-risk patients. The L92-13 study was characterized by short maintenance therapy; it resulted in poor EFS, particularly in the standard-risk (SR) group and boys. Females did significantly better than males in EFS in the early three studies. The gender difference was not significant in overall survival, partly because >60% of the males survived after the testicular relapse. Randomized studies in the former three protocols revealed that intermediate- or high-dose methotrexate therapy significantly reduced the testicular relapse rate. In the L95-14 study, gender difference disappeared in EFS. Contrary to the results of larger-scale studies, the randomized control study in the L95-14 reconfirmed with updated data that dexamethasone 8 mg/m(2) had no advantage over prednisolone 60 mg/m(2) in the SR and intermediate-risk groups. Prophylactic cranial irradiation was assigned to 100, 80, 44, and 44% of the patients in the studies, respectively. Isolated central nervous system relapse rates decreased to <2% in the last two trials. Secondary brain tumors developed in 12 patients at 8-22 years after cranial irradiation. Improvement of the remission induction rates and the complete omission of irradiation are currently main objectives in our studies.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Cranial Irradiation , Neoplasm Recurrence, Local/therapy , Neoplasms, Second Primary/therapy , Precursor Cell Lymphoblastic Leukemia-Lymphoma/therapy , Adolescent , Child , Child, Preschool , Chromosome Aberrations , Combined Modality Therapy , Female , Follow-Up Studies , Humans , Immunophenotyping , Infant , Japan , Male , Neoplasm Recurrence, Local/genetics , Neoplasm Recurrence, Local/pathology , Neoplasm, Residual , Neoplasms, Second Primary/genetics , Neoplasms, Second Primary/pathology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics , Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology , Prognosis , Remission Induction , Risk Factors , Survival Rate , Time Factors , Treatment Outcome
8.
Transplant Proc ; 41(9): 3931-3, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19917415

ABSTRACT

A 59-year-old man with hepatitis C virus-associated liver cirrhosis was transferred to our hospital to undergo living donor liver transplantation. Coagulation was impaired (prothrombin time [International Normalized Ratio], 3.27), and antithrombin III (AT-III) activity was 23% (normal, 87%-115%). Contrast-enhanced computed tomography scans revealed portal vein thrombosis (PVT) from the junction between the splenic and superior mesenteric vein to the porta hepatica; the portal vein was completely obstructed (PVT). To prevent further development of PVT, 1500 U of AT-III was administered for 3 days, elevating the AT-III activity to 50%. A contrast-enhanced computed tomography scan obtained 9 days after AT-III administration showed resolution of PVT. Living donor liver transplantation was safely performed without portal vein grafting. Thus, a low AT-III concentration may have an important role in the pathogenesis of PVT in patients with cirrhosis.


Subject(s)
Antithrombin III/therapeutic use , Hepatic Encephalopathy/surgery , Hepatitis C/complications , Liver Cirrhosis/surgery , Liver Transplantation/methods , Portal Vein/pathology , Venous Thrombosis/etiology , Venous Thrombosis/surgery , Bilirubin/blood , Humans , Living Donors , Male , Middle Aged , Portal Vein/diagnostic imaging , Portal Vein/drug effects , Portal Vein/surgery , Shock, Hemorrhagic/complications , Tomography, X-Ray Computed , Venous Thrombosis/diagnostic imaging
9.
Minim Invasive Neurosurg ; 51(6): 354-7, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19061148

ABSTRACT

Subarachnoid hemorrhages with intraventricular hemorrhage (IVH) have been treated with aneurysmal clipping and ventricular drainage. We present a combined treatment with coiling and endoscopy: coiling of the ruptured distal anterior cerebral artery aneurysm and neuroendoscopic removal of IVH.


Subject(s)
Aneurysm, Ruptured/surgery , Intracranial Hemorrhages/surgery , Minimally Invasive Surgical Procedures/methods , Neuroendoscopy/methods , Neurosurgical Procedures/methods , Aged , Aneurysm, Ruptured/complications , Female , Humans , Intracranial Hemorrhages/complications , Minimally Invasive Surgical Procedures/instrumentation , Neurosurgical Procedures/instrumentation , Treatment Outcome
10.
Inflammopharmacology ; 15(6): 288-92, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17952370

ABSTRACT

To clarify roles of H2S in regulation of gastric circulation, we investigated effects of NaHS, a H2S donor, on tension of isolated rat gastric artery and gastric mucosal blood flow in rats. In the precontracted ring preparations, NaHS caused contraction and relaxation at low and high concentrations, respectively. The NaHS-induced vasorelaxation was only partially blocked by glibenclamide, a K+ (ATP) channel inhibitor. The contractile activity of NaHS disappeared by removal of the endothelium or by inhibition of nitric oxide synthase and the endothelium-derived hyperpolarizing factor (EDHF) pathways. Intravenous injection of NaHS caused transient increase followed by decrease in gastric mucosal blood flow in rats. Collectively, in the gastric artery, NaHS appears to cause relaxation through both K+ (ATP) channel-dependent and -independent pathways and contraction through inhibition of NO and EDHF pathways. Together with the in vivo results, our study implies that H2S plays multiple complex roles in regulation of gastric circulation.


Subject(s)
Arteries/physiology , Gastric Mucosa/blood supply , Gastric Mucosa/physiology , Hydrogen Sulfide/pharmacology , Stomach/blood supply , Animals , Arteries/drug effects , Biological Factors/physiology , Blood Pressure/drug effects , Endothelium, Vascular/drug effects , Endothelium, Vascular/physiology , Gastric Mucosa/drug effects , Glyburide/pharmacology , In Vitro Techniques , KATP Channels/antagonists & inhibitors , Male , Muscle Contraction/drug effects , Muscle Contraction/physiology , Muscle Relaxation/drug effects , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth, Vascular/physiology , Nitric Oxide Synthase Type III/antagonists & inhibitors , Potassium Channel Blockers/pharmacology , Rats , Rats, Wistar , Regional Blood Flow/drug effects , Regional Blood Flow/physiology , Stomach/drug effects
11.
Bone Marrow Transplant ; 37(5): 469-77, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16435016

ABSTRACT

We retrospectively analyzed our results of 30 patients with three distinctive primary immunodeficiency diseases (PIDs)--severe combined immunodeficiency (SCID, n = 11), Wiskott-Aldrich syndrome (WAS, n = 11) and X-linked hyper-immunoglobulin M (IgM) syndrome (XHIM, n = 8)--who underwent hematopoietic SCT (HSCT) during the past 20 years. Until 1995, all donors were HLA-haploidentical relatives with T-cell depletion (TCD) (n = 8). Since 1996, the donors have been HLA-matched related donors (MRD) (n = 8), unrelated BM (UR-BM) (n = 7) and unrelated cord blood (UR-CB) (n = 7). Twenty-seven of 30 patients had various pre-existing infections with or without organ damages before HSCT. Conditioning regimen and GVHD prophylaxis were determined according to disease, donor and pretransplant status. Although one of eight patients transplanted with TCD is alive with full engraftment, the other seven died. On the other hand, 18 of 22 patients transplanted without TCD are alive and well, including six of eight transplanted from MRD, seven of seven from UR-BM and five of seven from UR-CB. All 19 survivors did not require Ig supplementation after HSCT. These results indicate that UR-CBT as well as UR-BMT provides good results for PID comparable to MRD-SCT, and that early diagnosis, HSCT at early stage, careful supportive therapy and monitoring for various pathogens are important for the successful HSCT.


Subject(s)
Hematopoietic Stem Cell Transplantation/methods , Immunologic Deficiency Syndromes/therapy , Adolescent , Adult , Child , Child, Preschool , Disease-Free Survival , Hematopoietic Stem Cell Transplantation/mortality , Humans , Immunologic Deficiency Syndromes/complications , Immunologic Deficiency Syndromes/mortality , Infant , Infections , Lymphocyte Depletion , Male , Retrospective Studies , Survival Rate , Tissue Donors , Transplantation Conditioning/methods
12.
J Appl Microbiol ; 96(6): 1215-21, 2004.
Article in English | MEDLINE | ID: mdl-15139912

ABSTRACT

AIMS: To investigate the effects of the salt concentration, incubation temperature and initial pH of the medium on the fermentative ability of the halophilic lactic acid bacteria, Tetragenococcus muriaticus and T. halophilus. METHOD AND RESULTS: The growth, lactic acid production and pH reduction ability of five strains of T. muriaticus and T. halophilus in MRS broth medium under various culture conditions such as salt concentration (3, 7, 15 and 23% NaCl), temperature (20, 30 and 40 degrees C), and initial medium pH (5.8, 6.5 and 7.5) were investigated. Those of T. halophilus were seriously affected by a high salinity (23% NaCl); in contrast, those of T. muriaticus were affected by a low initial pH (5.8). CONCLUSIONS: The results indicate that high saline concentrations and low pH values have significant impact on the growth, lactic acid production and pH reduction ability of T. halophilus and T. muriaticus, respectively. SIGNIFICANCE AND IMPACT OF THE STUDY: This study appears to be important in biopreservation during the manufacture of fermented food products. Both T. muriaticus and T. halophilus may support each other in reducing pH in hypersaline or low pH environment. To our knowledge, this is the first report on the fermentation ability of T. muriaticus.


Subject(s)
Food Microbiology , Lactic Acid/biosynthesis , Lactobacillus/metabolism , Dose-Response Relationship, Drug , Fermentation/drug effects , Hydrogen-Ion Concentration , Industrial Microbiology/methods , Lactobacillus/classification , Lactobacillus/drug effects , Sodium Chloride/administration & dosage , Temperature
13.
J Infect ; 44(3): 198-201, 2002 Apr.
Article in English | MEDLINE | ID: mdl-12099752

ABSTRACT

A 19-year-old female with aplastic anemia who developed subglottal aspergillosis is reported. She presented with fever, cough and stridor. Inspiratory dyspnea progressed rapidly and emergent tracheostomy was performed, which confirmed the diagnosis. In spite of intensive anti-fungal treatment combined with adoptive immunotherapy, Aspergillus infection expanded and she died of pulmonary aspergillosis. Autopsy revealed the fungal mass obstructing the trachea and disseminated pulmonary aspergillosis. Difficulties in diagnosis and management of subglottal Aspergillus infection are discussed.


Subject(s)
Anemia, Aplastic/complications , Anemia, Aplastic/microbiology , Aspergillosis/complications , Aspergillosis/microbiology , Aspergillus fumigatus/isolation & purification , Opportunistic Infections/complications , Opportunistic Infections/microbiology , Adult , Amphotericin B/therapeutic use , Anemia, Aplastic/drug therapy , Anti-Inflammatory Agents/therapeutic use , Antifungal Agents/therapeutic use , Aspergillosis/drug therapy , Aspergillosis/pathology , Fatal Outcome , Female , Fluconazole/therapeutic use , Humans , Itraconazole/therapeutic use , Larynx/microbiology , Larynx/pathology , Methylprednisolone/therapeutic use , Opportunistic Infections/drug therapy , Opportunistic Infections/pathology
14.
Pediatr Int ; 43(2): 124-7, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11285061

ABSTRACT

BACKGROUND: Doxapram is contraindicated for newborn infants in Japan because of its serious side effects. However, because of encouraging results of recent studies regarding the efficacy and safety of therapy for apnea of prematurity (AOP) with lower doses of doxapram than those previously proposed, approximately 60% of Japanese neonatologists continue to use doxapram at small doses. Caution is warranted because the sample sizes of the former studies are inadequate to evaluate doxapram for both its beneficial and harmful effects. Therefore, we conducted the present study in order to investigate the efficacy and harmful events of low-dose doxapram therapy for idiopathic AOP in very low-birth weight (VLBW) infants in a larger population. METHODS: One hundred and six VLBW infants with idiopathic AOP were treated with doxapram at a dose of 0.2-1.0 mg/kg per h in combination with methylxanthines and the frequency of apnea and secondary outcomes were compared with a group of control infants. RESULTS: An approximate 80% reduction in the frequency of apnea was found with only minimal side effects following low-dose doxapram. Although there were no significant differences in secondary outcomes between the doxapram-treated and control groups, mortality in doxapram-treated infants was significantly lower than that in control infants. CONCLUSIONS: Patients with AOP unresponsive to treatment with methylxanthines may benefit from the addition of low-dose doxapram.


Subject(s)
Apnea/drug therapy , Doxapram/administration & dosage , Infant, Premature, Diseases/drug therapy , Respiratory System Agents/administration & dosage , Apnea/etiology , Doxapram/adverse effects , Drug Therapy, Combination , Humans , Infant, Newborn , Infant, Premature , Infant, Premature, Diseases/etiology , Infant, Very Low Birth Weight , Recurrence , Respiratory System Agents/adverse effects , Treatment Outcome , Xanthines/therapeutic use
15.
J Neurosurg ; 94(2 Suppl): 221-6, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11302624

ABSTRACT

OBJECT: A variety of factors may affect surgery-related outcome in patients with ossification of the ligamentum flavum (OLF) of the thoracic spine. The aim of this study was to determine these factors on the basis of preoperative clinical and radiological findings. METHODS: The authors treated 31 cases of symptomatic thoracic OLF between 1988 and 1999. The following factors were retrospectively studied: patient age, sex, morbidity level, initial symptoms, chief complaint, duration of symptoms, patellar reflex, Achilles reflex, computerized tomography (CT) finding, presence of intramedullary change determined by magnetic resonance imaging, coexistent spinal lesions, preoperative grade, and postoperative grade. A decompressive laminectomy was performed in all cases. In 29 patients (94%) improved symptoms were demonstrated postoperatively. In terms of functional prognosis, the preoperative duration of symptoms was significantly shorter in the group of patients with excellent outcomes than in those with fair outcomes (p < 0.05). No significant difference was observed in the correlation between other factors. To evaluate the degree of preoperative thoracic stenosis and the severity/extent of OLF-induced spinal compression, we used an original OLF CT scoring system. A score of excellent on the CT scale tended to indicate an excellent prognosis (p < 0.01). CONCLUSIONS: Thoracic OLF frequently develops in the lower-thoracic spine in middle-aged men, and it is complicated by various spinal lesions in many cases. Early diagnosis and treatment are important for understanding the clinical symptoms and imaging diagnosis because the present findings suggest that a delay in diagnosis and treatment correlates with the functional prognosis postoperatively.


Subject(s)
Ligamentum Flavum , Ossification, Heterotopic/physiopathology , Thoracic Vertebrae , Adult , Aged , Female , Humans , Ligamentum Flavum/diagnostic imaging , Ligamentum Flavum/pathology , Magnetic Resonance Imaging , Male , Middle Aged , Ossification, Heterotopic/complications , Ossification, Heterotopic/diagnosis , Ossification, Heterotopic/surgery , Prognosis , Retrospective Studies , Severity of Illness Index , Spinal Cord Compression/diagnostic imaging , Spinal Cord Compression/etiology , Spinal Stenosis/diagnostic imaging , Thoracic Vertebrae/diagnostic imaging , Thoracic Vertebrae/pathology , Tomography, X-Ray Computed , Treatment Outcome
16.
J Forensic Odontostomatol ; 19(2): 22-5, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11813496

ABSTRACT

Direct digital X-ray technology was applied to dental identification of victims in two murder cases using the Compuray system. In both cases the digital radiography proved to be simple to use, quick and effective, allowing superimposition, enlargement and transportability to a mortuary. These are the first reported uses of the technology in Japan and further development promises the transmitability of data and images electronically to remote locations, further enhancing its usefulness. Comparing the skull with the dental ante-mortem X-ray films and records of a specific person who was reported "missing", we found many identical points between the two, especially in regard to the X-ray findings with the Compuray. In both cases we obtained a large number of X-ray images in a remarkably short time and this was very useful for identification by means of the teeth.


Subject(s)
Forensic Anthropology/methods , Forensic Dentistry/methods , Radiography, Dental, Digital , Adolescent , Female , Homicide , Humans , Japan
17.
Chem Pharm Bull (Tokyo) ; 49(12): 1507-11, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11767066

ABSTRACT

Liver disease is associated with an abnormal elevation of the plasma concentrations of the aromatic amino acids phenylalanine and tyrosine. The liver is the main site of aromatic amino acid metabolism, particularly the hydroxylation of phenylalanine to tyrosine and further tyrosine degradation. In the present study, we have examined the usefulness of the L-[1-13C]phenylalanine breath test (13C-PheBT) and L-[13C]tyrosine breath test (13C-TyrBT) for the detection of hepatic damage in patients with liver cirrhosis. First, the time courses of 13CO2 excretion after the administration of L-[1-13C]phenylalanine and L-[1-13C]tyrosine were compared. The peak times (the time expressed in minutes at which 13CO2 excretion was maximal) were 20 min in both breath tests, but 13C-TyrBT gave a higher peak than 13C-PheBT. Next, the parameters of 13C-PheBT and 13C-TyrBT were compared with biochemical liver function test values. These parameters were well correlated with several liver blood test values conventionally regarded as measures of hepatocyte functional reserve. Therefore, 13C-PheBT and 13C-TyrBT may be useful to assess the degree and progression of hepatic dysfunction.


Subject(s)
Breath Tests/methods , Hepatocytes/metabolism , Liver Cirrhosis/diagnosis , Liver Function Tests/methods , Phenylalanine , Tyrosine , Adult , Aged , Carbon Dioxide/metabolism , Female , Humans , Liver Cirrhosis/metabolism , Male , Middle Aged , Phenylalanine/pharmacokinetics , Tyrosine/pharmacokinetics
18.
Oncol Res ; 12(1): 17-24, 2000.
Article in English | MEDLINE | ID: mdl-11061342

ABSTRACT

For natural killer cell-mediated cytolysis (NK-lysis) and lymphokine-activated killer cell-mediated cytolysis (LAK-lysis), the co-stimulatory signals of CD18/CD54(+CD102) and CD2/CD58 pathways are essential. However, in this report, we describe a LAK-lysis that does not depend upon these two pathways. The killed cells were glioblastoma cell lines T98G and U373MG. The LAK cells were induced from peripheral blood lymphocytes in the presence of interleukin-2. 1) The T98G and U373MG did not express CD54 or CD102, but expressed CD58. 2) However, when they were pretreated with an anti-CD58 (TS2/9), the LAK-lysis was not blocked. 3) The LAK-lysis was markedly inhibited by pretreating with Concanamycin A and slightly inhibited by treating with antitumor necrosis factor-related apoptosis-inducing ligand (anti-TRAIL) antibody. 4) Nineteen percent of the LAK cells adhered to the T98G. The adhered LAK cells killed it. But nonadherent LAK cells could not kill the T98G or U373MG but killed lymphoblastoma cell lines Raji and NALM-6. These findings suggested that this type of the LAK-lysis might not depend upon the CD18/CD54(+CD102) pathway or CD2/CD58 pathway. The effector cells that killed the T98G and U373MG might not always be the same as the effector cells that killed the other cell lines. The LAK cells contain several subsets, and one of the subsets might kill these two target cell lines.


Subject(s)
Antigens, CD/immunology , Cytotoxicity, Immunologic , Glioblastoma/immunology , Killer Cells, Lymphokine-Activated/immunology , CD18 Antigens/immunology , CD2 Antigens/immunology , CD58 Antigens/immunology , Cell Adhesion , Cell Adhesion Molecules/immunology , Chromium/chemistry , Humans , Intercellular Adhesion Molecule-1/immunology , Interferon-gamma/biosynthesis , Killer Cells, Natural/immunology , Lymphoma, Non-Hodgkin/immunology , Tumor Cells, Cultured/immunology , Tumor Necrosis Factor-alpha/biosynthesis
19.
Exp Hematol ; 28(10): 1174-80, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11027836

ABSTRACT

OBJECTIVE: To characterize CD33(+)CD34(+) cells, a major population in human cord blood (CB) CD34(+) cells of preterm neonates. MATERIALS: The proportion of CD33(+) cells was analyzed on CB CD34(+) cells from preterm and full-term neonates. CD33(+)CD34(+) cells were purified by cell sorting and analyzed on their clonogenic activity, proliferative activity in short-time liquid suspension culture, and GATA-2 mRNA expression by RT-PCR and Southern blot. RESULTS: The absolute numbers and proportion of CD34(+) cells in mononuclear cells inversely correlated with gestational age. CD33 was expressed on a majority of CB CD34(+) cells of preterm neonates but on only a minor population of them in full-term neonates. In addition, CD33 was dominantly expressed on CD38(-)CD34(+) cells or CD117(low)CD34(+) cells in CB of preterm neonates. CD33(+)CD34(+) cells of preterm cord blood had high proliferative and reproducible potentials compared with CD33(-)CD34(+) cells. CD33(+)CD34(+) cells as well as CD33(-)CD34(+) cells from preterm CB highly expressed GATA-2, in contrast to those from BM. CONCLUSIONS: These results suggest that CD33(+)CD34(+) cells, which are a major population in CB CD34(+) cells of preterm neonates, do not simply represent relatively mature myeloid lineage hematopoietic progenitor cells as those in adult BM CD34(+) cells, and may contain hematopoietic stem cells or primitive progenitor cells as in fetal liver.


Subject(s)
Antigens, CD34/analysis , Antigens, CD/analysis , Antigens, Differentiation, Myelomonocytic/analysis , Fetal Blood/cytology , Hematopoietic Stem Cells/immunology , Immunophenotyping , Infant, Premature/blood , Blotting, Southern , Bone Marrow Cells/chemistry , Cell Separation , Cells, Cultured , DNA-Binding Proteins/genetics , Flow Cytometry , GATA2 Transcription Factor , Gene Expression , Hematopoietic Stem Cells/cytology , Humans , Infant, Newborn , RNA, Messenger/analysis , Reverse Transcriptase Polymerase Chain Reaction , Sialic Acid Binding Ig-like Lectin 3 , Transcription Factors/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...